David C. Linehan

David C. Linehan

University of Rochester

H-index: 67

North America-United States

About David C. Linehan

David C. Linehan, With an exceptional h-index of 67 and a recent h-index of 43 (since 2020), a distinguished researcher at University of Rochester, specializes in the field of tumor immunology, HPB surgery.

His recent articles reflect a diverse array of research interests and contributions to the field:

A phase 1b/2 trial of pepinemab and avelumab as second line therapy for patients with metastatic pancreatic adenocarcinoma.

Abstract A035: Stromal composition, fibroblast heterogeneity and spatial organization in pancreatic adenocarcinoma

Smad4 restricts injury-provoked biliary proliferation and carcinogenesis

Determination of permissive and restraining cancer-associated fibroblast (DeCAF) subtypes

Cd73 and PD-L1 dual blockade Amplifies antitumor efficacy of SBRT in murine PDAC models

Phase 1b/2 trial of pepinemab plus avelumab as second line combination immunotherapy for patients with metastatic pancreatic adenocarcinoma.

Predictors of opioid-free discharge after laparoscopic cholecystectomy

Radiation therapy exacerbates tumor-promoting innervation and nerve signaling in rectal cancer

David C. Linehan Information

University

Position

Professor of Surgery

Citations(all)

21294

Citations(since 2020)

8439

Cited By

16173

hIndex(all)

67

hIndex(since 2020)

43

i10Index(all)

130

i10Index(since 2020)

98

Email

University Profile Page

Google Scholar

David C. Linehan Skills & Research Interests

tumor immunology

HPB surgery

Top articles of David C. Linehan

Title

Journal

Author(s)

Publication Date

A phase 1b/2 trial of pepinemab and avelumab as second line therapy for patients with metastatic pancreatic adenocarcinoma.

Bailey Hilty

Luis I Ruffolo

Brian A Belt

Matthew Byrne

Yatee A Dave

...

2024/1/20

Abstract A035: Stromal composition, fibroblast heterogeneity and spatial organization in pancreatic adenocarcinoma

Cancer Research

Dalia Elganainy

Andressa Dias Costa

Alexander Jordan

Suryun Kim

Sara A Väyrynen

...

2024/1/16

Smad4 restricts injury-provoked biliary proliferation and carcinogenesis

Disease Models & Mechanisms

William B Alexander

Wenjia Wang

Margaret A Hill

Michael R O'Dell

Luis I Ruffolo

...

2024/6/1

Determination of permissive and restraining cancer-associated fibroblast (DeCAF) subtypes

Cancer Research

Xianlu Laura Peng

Elena Kharitonova

Joseph Kearney

Yi Xu

Priscilla Chan

...

2024/3/22

Cd73 and PD-L1 dual blockade Amplifies antitumor efficacy of SBRT in murine PDAC models

Journal for Immunotherapy of Cancer

Jian Ye

Nicholas W Gavras

David C Keeley

Angela L Hughson

Gary Hannon

...

2023

Phase 1b/2 trial of pepinemab plus avelumab as second line combination immunotherapy for patients with metastatic pancreatic adenocarcinoma.

Luis I Ruffolo

Terrence Lee Fisher

Elizabeth E Evans

Crystal L Mallow

Megan Boise

...

2023/6/1

Predictors of opioid-free discharge after laparoscopic cholecystectomy

The American Journal of Surgery

Alexa D Melucci

Yatee A Dave

Olivia F Lynch

Shawn Hsu

Mariah R Erlick

...

2023/1/1

Radiation therapy exacerbates tumor-promoting innervation and nerve signaling in rectal cancer

International Journal of Radiation Oncology* Biology* Physics

Taylor P Uccello

Maggie L Lesch

Nicholas A Ullman

Sarah A Kintzel

Lauren B Gradzewicz

...

2023/3/1

Spatially resolved single-cell assessment of pancreatic cancer expression subtypes reveals co-expressor phenotypes and extensive intratumoral heterogeneity

Cancer research

Hannah L Williams

Andressa Dias Costa

Jinming Zhang

Srivatsan Raghavan

Peter S Winter

...

2023/2/3

Local Delivery of SBRT and IL12 by mRNA Technology Overcomes Immunosuppressive Barriers to Eliminate Pancreatic Cancer

bioRxiv

Angela L Hughson

Gary Hannon

Noah A Salama

Tara G Vrooman

Caroline A Stockwell

...

2023/11/2

The divergent role of the GM-CSF/GM-CSFR signaling pathway in cholangiocarcinoma and pancreatic ductal adenocarcinoma.

Yatee A Dave

Paul R Burchard

Luis I Ruffolo

Nicholas A Ullman

Mary Georger

...

2023/2/1

New insights into the responder/nonresponder divide in rectal cancer: Damage-induced Type I IFNs dictate treatment efficacy and can be targeted to enhance radiotherapy

Cell Death & Disease

Taylor P Uccello

Maggie L Lesch

Sarah A Kintzel

Lauren B Gradzewicz

Lillia Lamrous

...

2023/7/26

Vitamin D Receptor Antagonist MeTC7 Inhibits PD-L1

Cancers

Negar Khazan

Emily R Quarato

Niloy A Singh

Cameron WA Snyder

Taylor Moore

...

2023/6/30

A phase 1B/2 trial of avelumab and pepinemab as second line for metastatic pancreatic adenocarcinoma

HPB

LI Ruffolo

KM Jackson

NA Ullman

PR Burchard

M Georger

...

2023/1/1

Early Postoperative ERAS Compliance is Associated with Decreased Length of Stay and Complications Following Liver Resection

HPB

P Burchard

Y Dave

A Loria

N Parikh

K Pineda-Solis

...

2022/1/1

Abstract PO025: GM-CSF neutralization enhances the efficacy of chemotherapy in an orthotopic murine model of cholangiocarcinoma

Clinical Cancer Research

Yatee A Dave

Paul R Burchard

Nicholas A Ullman

Mary Georger

Luis I Ruffolo

...

2022/9/1

GM-CSF drives myelopoiesis, recruitment and polarisation of tumour-associated macrophages in cholangiocarcinoma and systemic blockade facilitates antitumour immunity

Gut

Luis I Ruffolo

Katherine M Jackson

Peyton C Kuhlers

Benjamin S Dale

Nathania M Figueroa Guilliani

...

2022/7/1

Cyclooxygenase-2 Inhibition with Celecoxib Delays Tumor Growth in an Orthotopic Murine Model of Cholangiocarcinoma–A Novel Therapeutic Strategy for Cholangiocarcinoma

HPB

Y Dave

P Burchard

A Chacon

L Ruffolo

N Ullman

...

2022/1/1

Intrathecal morphine and effect on opioid consumption and functional recovery after pancreaticoduodenectomy

Journal of the American College of Surgeons

Paul R Burchard

Alexa D Melucci

Olivia Lynch

Anthony Loria

Yatee A Dave

...

2022/9/1

" Reverse abscopal effect": Immunologically cold tumors alter systemic immunity and confer PD-1 resistance to immunologically hot tumors in synchronous melanoma

Cancer Research

Shuyang S Qin

Booyeon J Han

Alexander C Chacon

Alexa D Melucci

Alyssa R Williams

...

2022/6/15

See List of Professors in David C. Linehan University(University of Rochester)